Peer Review History

Original SubmissionOctober 3, 2021
Decision Letter - Frank JMF Dor, Editor

PONE-D-21-31779Assessment of cognitive functioning after living kidney donation: a cross-sectional pilot study.PLOS ONE

Dear Dr. de Zwaan,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Based on the review by two experts in the field, I would recommend to thoroughly revise the MS based on the comments, which are minor, but need to be reassessed by the reviewer. Please provide point-by-point comments to the reviewers comments and questions. This is not a guarantee for acceptance of the revised MS.

==============================

Please submit your revised manuscript by Feb 04 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Frank JMF Dor, M.D., Ph.D., FEBS, FRCS

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for asking me to review this manuscript looking at cognitive function in living kidney donors.

I have a few points which I feel require further clarification:

1. Was there a reason why the quality of life measures were not given to the control group?

2. Did you do a sample size calculation?

3. Why were patients with mental health problems excluded?

I have minor comments re the language:

Line 50: the term ‘deceased donation’ is considered more appropriate than post-mortem donation

Line 51: I wouldn’t call rehospitalisation a side-effect – it is a complication

Line 53: Long run ought to be long term

Line 56-59: I am unsure of what is meant by “A meta-analysis could show…”

Line 154: There is a typo – der instead of the

Line 244: I would remove the word ‘group’

Line 253-258: These three sentences are written poorly and are confusing in what they are trying to say. Please rephrase these.

Reviewer #2: This is a thorough and diligently performed study, well designed, with a clear research questions, clearly and accurately written. I have no comments for improvement. The study can be published as it is. If I would have a minor comment it would refer to how the authors explain the reduced scores in working memory, slower reaction times and divided attention, meaning how do they explain the relationship between eGFR and these low scores... Do they assume it is a physical parameter making the difference? Or could it be that living kidney donors have an additional "worry" as in an affective rumination going on permanently related to the loss of their kidney and a potential risk for kidney function due to donation that affects working memory? Please consider this maybe unorthodox idea more of a comment in terms of an informal academic exchange rather than a comment for revision or improvement.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Editor

With regard to the data sharing requirements of PlosOne we now provide all relevant data as Supporting Information files.

Reviewer #1

I have a few points, which I feel require further clarification:

1. Was there a reason why the quality of life measures were not given to the control group?

The main quality of life instrument, the SF-12 (with the subscales PCS and MCS), was actually completed also by the controls (see Table 1). We found no difference between groups and both groups showed scores within the normal range for quality of life. Only the living donors filled out the other self-rating measures (fatigue, depressive and anxiety symptoms) as part of a more comprehensive assessment battery within the follow-up study.

2. Did you do a sample size calculation?

This investigation was designed as a pilot study. Since this is the first study investigating cognitive functioning in individuals after living kidney donation, we did not have a solid database for a power calculation.

3. Why were patients with mental health problems excluded?

Mental disorders such as depression can affect cognitive performance. We wanted to eliminate one strong potentially confounding factor. As mentioned in the discussion, “Depression is known to affect cognitive functioning”. We supported this statement by citing two references:

39. Ahern E, Semkovska M. Cognitive functioning in the first-episode of major depressive disorder: a systematic review and meta-analysis. Neuropsychology. 2017;31:52–72.

40. Liu J, Liu B, Wang M, Ju Y, Dong Q, Lu X, et al. Evidence for progressive cognitive deficits in patients with major depressive disorder. Front Psychiatry. 2021;12:627695.

I have minor comments re the language:

We thank the reviewer for carefully reading and editing the manuscript. We followed the suggested changes.

Line 50: the term ‘deceased donation’ is considered more appropriate than post-mortem donation.

We agree with the reviewer’s suggestion and substituted “post-mortem” with “deceased”.

Line 51: I wouldn’t call rehospitalisation a side-effect – it is a complication

We changed the wording accordingly.

Line 53: Long run ought to be long term

We changed “long run” to “long term”.

Line 56-59: I am unsure of what is meant by “A meta-analysis could show…”

We re-phrased the sentence: “A systematic review revealed that most, but not all, cross-sectional and longitudinal studies suggest an association between cognitive impairment and CKD.”

Line 154: There is a typo – der instead of the

We corrected the typo. Thanks for catching that.

Line 244: I would remove the word ‘group’

We omitted the word “group”

Line 253-258: These three sentences are written poorly and are confusing in what they are trying to say. Please rephrase these.

The sentences were re-written and readability should be improved.

“Regarding the pattern of abnormal cognitive test results, we found similarities and differences between our sample of LKD and individuals with CKD in general population samples. General and visual attention and concentration was impaired in the LKD in our study similarly to individuals with CKD in population samples. However, in contrast to the LKD in our study, individuals with CKD frequently also exhibit memory impairment [10-12, 34].”

Reviewer #2

This is a thorough and diligently performed study, well designed, with a clear research questions, clearly and accurately written. I have no comments for improvement. The study can be published as it is. If I would have a minor comment, it would refer to how the authors explain the reduced scores in working memory, slower reaction times and divided attention, meaning how do they explain the relationship between eGFR and these low scores... Do they assume it is a physical parameter making the difference? Or could it be that living kidney donors have an additional "worry" as in an affective rumination going on permanently related to the loss of their kidney and a potential risk for kidney function due to donation that affects working memory? Please consider this maybe unorthodox idea more of a comment in terms of an informal academic exchange rather than a comment for revision or improvement.

We thank the reviewer for his/her supporting comments. It might be possible that “worries” influence cognitive performance; however, in our experience with working with living donors this is not a frequent problem. In addition, as can be seen in Table 1, quality of life, depression, anxiety, fatigue and levels of distress were within normal ranges.

Attachments
Attachment
Submitted filename: Response to reviewers Neurokid.docx
Decision Letter - Frank JMF Dor, Editor

Assessment of cognitive functioning after living kidney donation: a cross-sectional pilot study.

PONE-D-21-31779R1

Dear Dr. de Zwaan,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Frank JMF Dor, M.D., Ph.D., FEBS, FRCS

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for addressing the comments.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for addressing my comments. I have nothing further to add.

Reviewer #2: The authors have addressed the minor comments raised by the reviewers. No other comments from my side. The paper can be accepted.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Frank JMF Dor, Editor

PONE-D-21-31779R1

Assessment of cognitive functioning after living kidney donation: a cross-sectional pilot study.

Dear Dr. de Zwaan:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Frank JMF Dor

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .